Medicare Enrolled
Dr. Michael Hait, M.D.
Rheumatology · Dartmouth, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hait from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hait?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hait
Dr. Michael Hait is a rheumatology specialist in Dartmouth, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hait performed 13,073 Medicare services across 3,294 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hait received a total of $5,788 from 21 pharmaceutical and/or device companies across 295 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hait is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in MA
$5,788 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,073
Medicare services
Top 9% in MA for rheumatology
3,294
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~654 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,920 | $18 | $43 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
816 | $8 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
721 | $64 | $224 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
471 | $5 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
460 | $89 | $334 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
377 | $3 | $40 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
353 | $1 | $5 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
294 | $10 | $40 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
182 | $11 | $67 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
165 | $6 | $20 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
109 | $5 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
103 | $109 | $509 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
90 | $6 | $325 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
78 | $21 | $112 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
68 | $8 | $40 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
67 | $102 | $534 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
65 | $4 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
64 | $132 | $393 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
61 | $13 | $40 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
55 | $48 | $237 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
55 | $1 | $8 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
54 | $2 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
45 | $45 | $251 |
| Rheumatoid factor level | 41 | $5 | $20 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
40 | $9 | $29 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
37 | $16 | $50 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
32 | $8 | $25 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
30 | $5 | $40 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
30 | $5 | $20 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
29 | $31 | $82 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
27 | $6 | $20 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
25 | $66 | $183 |
| Fecal immunochemical test (FIT), 1-3 simultaneous A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer. |
25 | $18 | $63 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
19 | $14 | $49 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
17 | $40 | $120 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
17 | $19 | $80 |
| PSA test (prostate cancer screening) | 16 | $17 | $80 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
15 | $13 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
66.4% medium
32.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,788
Total received (2018-2024)
Avg $827/year across 7 years
Top 30% in MA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
295
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,688 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,203
2023
$686
2022
$1,011
2021
$986
2020
$603
2019
$172
2018
$127
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$793
Amgen Inc.
$468
Janssen Biotech, Inc.
$338
AstraZeneca Pharmaceuticals LP
$147
GENZYME CORPORATION
$119
UCB, Inc.
$110
Fresenius Kabi USA, LLC
$78
GlaxoSmithKline, LLC.
$74
SOBI, INC
$29
SCILEX PHARMACEUTICALS INC.
$25
Sandoz Inc.
$22
Top 3 companies account for 72.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,575
Amgen Inc.
$1,372
Janssen Biotech, Inc.
$776
AbbVie Inc.
$366
Lilly USA, LLC
$331
AstraZeneca Pharmaceuticals LP
$251
Hikma Pharmaceuticals USA
$169
UCB, Inc.
$126
GENZYME CORPORATION
$119
E.R. Squibb & Sons, L.L.C.
$112
GlaxoSmithKline, LLC.
$100
Genentech USA, Inc.
$100
AbbVie, Inc.
$87
Fresenius Kabi USA, LLC
$78
PFIZER INC.
$52
Horizon Therapeutics plc
$44
Novartis Pharmaceuticals Corporation
$34
SOBI, INC
$29
SCILEX PHARMACEUTICALS INC.
$25
Sandoz Inc.
$22
Alexion Pharmaceuticals, Inc.
$21
Top 3 companies account for 64.3% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · FASENRA · HUMIRA · HYRIMOZ · Humira · IDACIO · KEVZARA · KINERET · KRYSTEXXA · Mitigare · OLUMIANT · ORENCIA · Otezla · REMICADE · RINVOQ · Rinvoq · SAPHNELO · SKYRIZI · TALTZ · TAVNEOS · TREMFYA · ULTOMIRIS · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
28
Per 100K population
4.8
County median income
$84,198
Nearest hospital
SOUTHCOAST BEHAVIORAL HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hait is a mixed practice specialist, with above-average Medicare volume (top 9% in MA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hait experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Hait performed 7,920 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hait receive payments from pharmaceutical companies?
Yes. Dr. Hait received a total of $5,788 from 21 companies across 295 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hait's costs compare to other rheumatologists in Dartmouth?
Dr. Hait's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hait) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Dartmouth
Browse rheumatologists in Dartmouth ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in MA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in MA
Which MA rheumatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology